Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | Class A Common | Tax liability | -$362K | -1.12K | -2.61% | $323.80 | 41.7K | Mar 1, 2023 | Direct | F1 |
transaction | SAM | Class A Common | Award | $0 | +6.18K | +14.8% | $0.00 | 47.9K | Mar 1, 2023 | Direct | F2, F3 |
holding | SAM | Class A Common | 10.5K | Mar 1, 2023 | In a Spousal Lifetime Access Trust for the benefit of the Reporting Person's Spouse |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | March 1, 2019 Stock Option | Award | $0 | +2.45K | +50.01% | $0.00 | 7.35K | Mar 1, 2023 | Class A Common | 7.35K | $312.56 | Direct | F4 |
transaction | SAM | March 1, 2020 Stock Option | Award | $0 | +2.34K | +50% | $0.00 | 7.03K | Mar 1, 2023 | Class A Common | 7.03K | $370.79 | Direct | F5 |
transaction | SAM | March 1, 2021 Stock Option | Award | $0 | +1.48K | +50% | $0.00 | 4.45K | Mar 1, 2023 | Class A Common | 4.45K | $1,028.71 | Direct | F6 |
transaction | SAM | March 1, 2023 Stock Option | Award | $0 | +12.4K | $0.00 | 12.4K | Mar 1, 2023 | Class A Common | 12.4K | $323.80 | Direct | F7 |
Id | Content |
---|---|
F1 | The Issuer "net withheld" the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 3,264 RSUs vest on March 1, 2023. |
F2 | On March 1, 2023, the Issuer granted 6,177 RSUs to the Reporting Person under the Issuer's Employee Equity Incentive Plan ("EEIP"). The shares will vest in three installments over a three year period, provided that the Reporting Person remains employed by the Issuer on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
F3 | The shares reported include 16,597 shares of restricted stock subject to vesting conditions. |
F4 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2019. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2020 over Fiscal Year 2018. In February 2021, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vested in three equal installments on March 1 in the years 2021-2023. |
F5 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2020. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2021 over Fiscal Year 2019. In February 2022, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2022-2024, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
F6 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2021. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2022 over Fiscal Year 2020. In February 2023, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2023-2025, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
F7 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2023. The extent to which the options become exercisable is dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. The Compensation Committee will determine if the performance criteria have been achieved prior to March 1, 2025. If the performance criteria is achieved, the options vest in two installments on March 1 in the years 2025-2026, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |